Page last updated: 2024-09-03

imatinib mesylate and Myelodysplastic-Myeloproliferative Diseases

imatinib mesylate has been researched along with Myelodysplastic-Myeloproliferative Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cross, NC; Erben, P; Gosenca, D; Haferlach, C; Hänel, A; Hochhaus, A; Metzgeroth, G; Reiter, A; Walz, C1

Other Studies

1 other study(ies) available for imatinib mesylate and Myelodysplastic-Myeloproliferative Diseases

ArticleYear
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2).
    Genes, chromosomes & cancer, 2009, Volume: 48, Issue:2

    Topics: Antineoplastic Agents; Benzamides; Chromosome Painting; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 5; Eosinophilia; Gene Fusion; Humans; Imatinib Mesylate; Male; Middle Aged; Mutant Chimeric Proteins; Myelodysplastic-Myeloproliferative Diseases; Myosins; Piperazines; Polymerase Chain Reaction; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Translocation, Genetic

2009